|
Clinical Trials and Observations
Citations 421-430 of 2742 total displayed.
|
Past content
(since May 1998):
|
Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders
- Linda Morris Brown, Gloria Gridley, David Check, and Ola Landgren
Blood 2008; 111: 3388-3394.
[Abstract]
[Full text]
[PDF]
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
- Javier de la Serna, Pau Montesinos, Edo Vellenga, Chelo Rayón, Ricardo Parody, Angel León, Jordi Esteve, Juan M. Bergua, Gustavo Milone, Guillermo Debén, Concha Rivas, Marcos González, Mar Tormo, Joaquín Díaz-Mediavilla, Jose D. González, Silvia Negri, Elena Amutio, Salut Brunet, Bob Lowenberg, and Miguel A. Sanz
Blood 2008; 111: 3395-3402.
[Abstract]
[Full text]
[PDF]
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody–based therapy
- Ping Zhou, Raymond L. Comenzo, Adam B. Olshen, Ezio Bonvini, Scott Koenig, Peter G. Maslak, Martin Fleisher, James Hoffman, Suresh Jhanwar, James W. Young, Stephen D. Nimer, and Adam M. Boruchov
Blood 2008; 111: 3403-3406.
[Abstract]
[Full text]
[PDF]
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab
- Halvard Bonig, Annette Wundes, Kai-Hsin Chang, Sylvia Lucas, and Thalia Papayannopoulou
Blood 2008; 111: 3439-3441.
[Abstract]
[Full text]
[PDF]
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD
- Giancarlo Castaman, Stefan Lethagen, Augusto B. Federici, Alberto Tosetto, Anne Goodeve, Ulrich Budde, Javier Batlle, Dominique Meyer, Claudine Mazurier, Edith Fressinaud, Jenny Goudemand, Jeroen Eikenboom, Reinhard Schneppenheim, Jorgen Ingerslev, Zdena Vorlova, David Habart, Lars Holmberg, John Pasi, Frank Hill, Ian Peake, and Francesco Rodeghiero
Blood 2008; 111: 3531-3539.
[Abstract]
[Full text]
[PDF]
DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL
- Stéphanie Dulucq, Geneviève St-Onge, Vincent Gagné, Marc Ansari, Daniel Sinnett, Damian Labuda, Albert Moghrabi, and Maja Krajinovic
Blood 2008; 111: 3692-3700.
[Abstract]
[Full text]
[PDF]
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor- B pathways in subtypes of diffuse large B-cell lymphoma
- Lloyd T. Lam, George Wright, R. Eric Davis, Georg Lenz, Pedro Farinha, Lenny Dang, John W. Chan, Andreas Rosenwald, Randy D. Gascoyne, and Louis M. Staudt
Blood 2008; 111: 3701-3713.
[Abstract]
[Full text]
[PDF]
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
- Sai Li, Robert Kralovics, Gennaro De Libero, Alexandre Theocharides, Heinz Gisslinger, and Radek C. Skoda
Blood 2008; 111: 3863-3866.
[Abstract]
[Full text]
[PDF]
Genetic endothelial systems biology of sickle stroke risk
- Liming Chang Milbauer, Peng Wei, Judy Enenstein, Aixiang Jiang, Cheryl A. Hillery, J. Paul Scott, Stephen C. Nelson, Vidya Bodempudi, James N. Topper, Ruey-Bing Yang, Betsy Hirsch, Wei Pan, and Robert P. Hebbel
Blood 2008; 111: 3872-3879.
[Abstract]
[Full text]
[PDF]
The monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
- Fabian Zohren, Diamandis Toutzaris, Viola Klärner, Hans-Peter Hartung, Bernd Kieseier, and Rainer Haas
Blood 2008; 111: 3893-3895.
[Abstract]
[Full text]
[PDF]
|
|
